HERON THERAPEUTICS INC (HRTX) Stock Balance Sheet
NASDAQ:HRTX - Nasdaq - US4277461020 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.27M | 25.80M | 28.68M | 15.40M | 90.50M | |||
| Marketable Securities | 31.41M | 33.48M | 51.73M | 69.50M | 67.00M | |||
| Receivables | 78.74M | 78.88M | 60.14M | 52.00M | 35.50M | |||
| Inventories | 56.93M | 53.16M | 42.11M | 54.60M | 48.40M | |||
| Other Current Assets | 26.49M | 17.69M | 6.12M | 14.00M | 13.00M | |||
| Total Current Assets | 212.84M | 209.01M | 188.77M | 205.40M | 254.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.63M | 17.65M | 25.60M | 29.80M | 33.60M | |||
| Other Non-Current Assets | 6.28M | 6.48M | 8.13M | 15.70M | 17.70M | |||
| Total Non-Current Assets | 22.91M | 24.13M | 33.73M | 45.60M | 51.30M | |||
| TOTAL ASSETS | 235.75M | 233.15M | 222.51M | 251.00M | 305.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 76.22M | 78.69M | 75.47M | 78.10M | 66.60M | |||
| Accounts Payable | 12.33M | 11.71M | 3.24M | 3.20M | 3.80M | |||
| Other Current Liabilities | N/A | 1.06M | 974.00K | 1.00M | 600.00K | |||
| Total Current Liabilities | 88.56M | 91.46M | 79.69M | 82.40M | 71.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 149.75M | 149.70M | 149.49M | 149.30M | 149.10M | |||
| Other Non-Current Liabilities | 25.89M | 25.64M | 27.30M | 5.70M | 8.00M | |||
| Total Non-Current Liabilities | 175.65M | 175.34M | 176.79M | 155.00M | 157.00M | |||
| TOTAL LIABILITIES | 264.20M | 266.80M | 256.48M | 237.40M | 228.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.92B | -1.92B | -1.91B | -1.80B | -1.61B | |||
| Additional Paid In Capital | 1.89B | 1.88B | 1.87B | 1.81B | 1.69B | |||
| Common Shares | 1.52M | 1.52M | 1.50M | 1.20M | 1.00M | |||
| Other Shareholders' Equity | 1.00K | 13.00K | 13.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 152.43M | 152.13M | 150.28M | 119.20M | 102.00M | |||
| Tangible Book Value per Share | -0.19 | -0.22 | -0.23 | 0.11 | 0.76 | |||
| Total Shareholders' Equity | -28.45M | -33.65M | -33.97M | 13.60M | 77.60M | |||
| TOTAL LIABILITIES AND EQUITY | 235.75M | 233.15M | 222.51M | 251.00M | 305.70M | |||
| Statistics | ||||||||
| Debt/Equity | -5.26 | -4.45 | -4.40 | 10.98 | 1.92 | |||
| Current Ratio | 2.40 | 2.29 | 2.37 | 2.49 | 3.58 | |||
| Return On Assets (ROA) | -3.30% | -5.82% | -49.69% | -72.51% | -72.19% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -1338.24% | -284.41% | |||
All data in USD , ROIC based on taxRate of 0.21